how to open vial of semaglutide a vial, pen, or tablet pack Starting first dose! A little
Description
In our most recent data set, we still see most users taking GLP-1s for diabetes, however the percentage of users taking GLP-1s for weight loss continues to trend up
S., Hammer, M., Zychma, M
the other third received the same lifestyle intervention with a placebo
So this is a growing threat that I think needs to be monitored closely. If GLP-1s do become prohibited, athletes could theoretically apply for a therapeutic use exemption (TUE), which allows them to take a drug if it is treating a legitimate medical condition, and does not meaningfully enhance their performance
